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Bioelectronic sensors that combine biomolecules as primary recognition 
elements and electronics as signal transducers have been extensively 
developed.1, 2 Biologically-inspired technologies for detection of target 
molecules increased the functionality of sensors with the nature system. 
Nanomaterial-based electronic devices rapidly amplify biological signals and 
convert into intuitive forms.3, 4, 5 Furthermore, many parts of living organisms 
are operated by action potentials so that they can be applied to the sensing 
mechanism of biolectronic sensors. Recently, various nanomaterials, such as 
carbon nanotube (CNT), graphene, nanoparticle, nanofiber, nanowire and 
nanofilm have been used in the fabrication of the bioelectronic sensors. Such 
nanomaterials were functionalized with biomolecules, such as DNA, protein, 
peptide, and cell for the specific binding. Advantages of using bioelectronic 




The objective of this research is to develop a CNT-based bioelectronic 
sensor using receptor proteins and peptides for various applications. Receptors 
receive external stimuli from out of the cell membrane and activate signal 
transduction pathways.6 The Receptors play important functions in the human 
body such as sensory transduction, cellular communication, neural 
transmission and hormonal signaling.7 In this study, receptor proteins were 
produced in forms of cell-derived nanovesicles, purified proteins and 
synthetic peptides. Their biological signals were monitored by The CNT-
based transducers and applied to environmental monitoring, disease diagnosis 
and food quality assessment. 
For the deorphanization of olfactory receptors, artificial olfactory cells 
were constructed using heterologous reporter gene systems.8 Specific 
receptors were screened for detection of potential biomarkers and evaluation 
of cell surface expression was performed. The cell-derived nanovesicles were 
constructed for the scalable signal transduction to the CNTs.9 A CNT-based 
field-effect transistor (FET) was fabricated via the conventional 
photolithography process.10 CNT channels were functionalized with 
nanovecsicles and the electrical properties of the CNT-FET were also 
maintained after the immobilization of nanovesicles. The nanovesicle-based 
bioelectronic sensor detected target biomarkers with high sensitivity and 
selectivity. The bioelectronic sensor using receptors presented simple rapid 
analytical methods for water quality monitoring and diabetes diagnosis. 
Developing a multiplexed platform and miniaturizing sensing device is 
necessary for practical applications of bioelectronic sensors. Four kinds of 
receptor proteins were expressed in Escherichia coli, purified and refolded 
with the detergent micelle methods. The proteins were immobilized onto the 
multi-type CNT channels which designed for simultaneous detection of the 
target molecules. A current monitoring device was customized for the multi-
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channel CNT-FET and operated by a laptop computer. Complex pattern 
recognitions of various molecules were available without any interference 
from non-target molecules. The simple portable bioelectronic device was 
suitable for efficient assessment of food quality and is expected to be used as 
a rapid on-site sensing platform. 
Receptor protein-derived peptides were synthesized based on the sequence 
of ligand binding sites and applied to the development of the bioelectronic 
sensor. The peptides do not require cell membrane-like environments so that 
they were easily stored.11 Furthermore, The synthesized peptides could 
directly immobilized onto the CNTs using the pi-pi interaction by simple 
modifications with additional phenylalanine residues.12, 13 The peptide-based 
bioelectronic sensor detected a serum biomarker of nerumyelitis optica with 
high specificity. Furthermore, the sensitivity was much higher so that the 
early-phase detection was available. 
In this research, bioelectronic sensor using carbon nanotubes and various 
types of receptors such as nanovesicles, proteins and peptides were developed 
for simple and rapid detection of the biomarkers. The developed sensors 
applied for the environmental monitoring, disease diagnosis and food quality 
assessment. 
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environmental monitoring, disease diagnosis, food quality assessment 
 





Chapter 1. Research background and objective ............................. 1 
 
Chapter 2. Literature review ........................................................... 5 
 2.1 Concept of bioelectronic sensor ................................................... 6 
     2.2 Biomolecules as primary recognition elements ............................. 7 
 2.2.1 DNA ................................................................................... 7 
 2.2.2 Protein ................................................................................. 7 
 2.2.3 Cell ..................................................................................... 8 
 2.3 Nanomaterials as secondary signal transducers ............................ 9 
 2.3.1 Carbon nanotube.................................................................. 9 
 2.3.2 Conducting polymer .......................................................... 11 
 2.3.3 Graphene ........................................................................... 11 
 2.4 Bioelectronic sensors using receptor proteins ............................. 12 
 2.4.1 Bioelectronic nose ............................................................. 12 
 2.4.2 Bioelectronic tongue .......................................................... 13 
 2.4.3 Applications ...................................................................... 14 
 
Chapter 3. Experimental procedures ............................................ 16 
 3.1 Gene cloning ............................................................................. 17 
 3.2 Production of receptor proteins .................................................. 17 
 3.2.1 Mammalian expression ...................................................... 17 
 3.2.2 Bacterial expression........................................................... 18 
 3.2.3 Construction of nanovesicles ............................................. 19 
 3.2.4 Synthesis of peptides ......................................................... 19 
 3.3 Characterization of receptor proteins ......................................... 19 
 3.3.1 CRE-Luciferase reporter gene assay .................................. 19 
v 
 
 3.3.2 Calcium influx assay ......................................................... 20 
 3.3.3 Immunocytochemistry ....................................................... 20 
 3.3.4 Western blot analysis ......................................................... 20 
 3.3.5 Scanning electron microscopy ........................................... 21 
 3.4 Construction of in vitro disease models...................................... 21 
 3.4.1 Cultivation of adipocytes and skeletal muscle cells ............ 21 
 3.4.2 2-Deoxyglucose uptake assay ............................................ 22 
 3.4.3 GC/MS analysis ................................................................ 22 
 3.5 Fabrication of bioelectronic sensor ............................................ 23 
 3.5.1 Fabrication of CNT-FET ................................................... 23 
 3.5.2 Fabrication of multi-channel CNT-FET ............................. 23 
 3.5.3 Immobilization of nanovesicle ........................................... 24 
 3.5.4 Immobilization of protein .................................................. 25 
 3.5.5 Immobilization of peptide .................................................. 25 
 3.5.5 Characterization of nanovesicle immobilization using SEM 25 
 3.5.6 Characterization of protein and peptide immobilization using 
AFM ................................................................................. 26 
 3.6 Electrical measurement.............................................................. 26 
 3.6.1 Single-channel measurement ............................................. 26 
 3.6.2 Multi-channel measurement ............................................... 26 
 
Chapter 4. Development of bioelectronic sensor using human 
olfactory nanovesicles for the detection of odor compounds in 
water pollution ............................................................................... 27 
 4.1 Introduction ............................................................................... 28 
 4.2 Screening of human olfactory receptors ..................................... 29 
 4.3 Characterization of olfactory nanovesicles ................................. 32 
 4.4 Construction of nanovesicle-based bioelectronic nose ................ 34 
 4.5 Detection of GSM and MIB using bioelectronic nose ................. 36 
vi 
 
 4.6 Detection of GSM and MIB from water samples........................ 42 
 4.7 Conclusions ............................................................................... 44 
 
Chapter 5. Development of bioelectronic sensor using human 
olfactory nanovesicles for the detection of VOCs from in vitro 
diabetic models ............................................................................... 45 
 5.1 Introduction ............................................................................... 46 
 5.2 Construction of in vitro diabetic models .................................... 47 
 5.3 Screening of human olfactory receptors ..................................... 50 
 5.4 Construction of nanovesicle-based bioelectronic nose ................ 52 
 5.5 Detection of 17ODYA using bioelectronic nose ......................... 55 
 5.6 Conclusions ............................................................................... 57 
 
Chapter 6. Development of portable and multiplexed bioelectronic 
sensor using human olfactory and taste receptor proteins for the 
assessment of food quality ............................................................. 58 
 6.1 Introduction ............................................................................... 59 
 6.2 Production of human sensory receptors ...................................... 60 
 6.3 Fabrication of multi-channel bioelectronic sensor ...................... 63 
 6.4 Detection of odor and taste molecules using bioelectronic sensor 69 
 6.5 Assessment of food freshness using biotelectronic sensor .......... 74 
 6.6 Conclusions ............................................................................... 77 
 
Chapter 7. Development of peptide-based bioelectronic sensor 
using extracellular loops of aquaporin for the diagnosis of 
neuromyelitis optica ....................................................................... 78 
 7.1 Introduction ............................................................................... 79 
 7.2 Construction of peptide-based bioelectronic sensor .................... 80 
vii 
 
 7.3 Electrical characteristics of peptide-based bioelectronic sensor .. 83 
 7.4 Detection of AQP4 antibody using bioelectronic sensor ............. 85 
 7.5 Detection of AQP4 antibody in human serum using bioelectronic 
sensor ....................................................................................... 87 
 7.6 Conclusions ............................................................................... 89 
 
Chapter 8. Overall discussion and further suggestions ................ 90 
 
Bibliography ................................................................................... 95 
 




List of Figures 
Figure 2.1 Sensing principles of CNT-FET ............................................... 10 
Figure 4.1 Screening of human olfactory receptors ................................... 30 
Figure 4.2 Expression of human olfactory receptors in mammalian cells. .. 31 
Figure 4.3 Characterization of olfactory nanovesicles ............................... 33 
Figure 4.4 Characterization of nanovesicle-based bioelectronic nose ........ 35 
Figure 4.5 Detection of GSM and MIB using bioelectronic nose ............... 38 
Figure 4.6 Response of bioelectronic nose without olfactory nanovesicle.. 39 
Figure 4.7 Selectivity of bioelectronic nose .............................................. 40 
Figure 4.8 Effect of ion channel blocker on the bioelectronic nose ............ 41 
Figure 4.9 Detection of GSM and MIB from water samples ...................... 43 
Figure 5.1 Construction of in vitro diabetic models................................... 48 
Figure 5.2 Analysis of VOCs in the headspace of diabetes model cells using 
SPME-GC/MS .......................................................................................... 49 
Figure 5.3 Screening of human olfactory receptors ................................... 51 
Figure 5.4 Characterization of olfactory nanovesicles ............................... 53 
Figure 5.5 Characterization of nanovesicle-based bioelectronic nose ........ 54 
Figure 5.6 Detection of 17ODYA using bioelectronic nose ....................... 56 
Figure 6.1 Functional production of human olfactory and taste receptors. . 62 
Figure 6.2 Fabrication and characterization of multi-channel CNT-FET ... 66 
Figure 6.3 Effect of the channel number on the standard deviations .......... 68 
Figure 6.4 Detection of target molecules using customized monitoring 
platform. .................................................................................. 71 
Figure 6.5 Responses of pristine CNT-FET .............................................. 73 
Figure 6.6 Signal pattern analysis of various food samples ....................... 76 
Figure 7.1 Schematic diagram showing the sensing mechanism of an AQP4 
loop peptide-based CNT-FET biosensor ................................... 81 
Figure 7.2 Immobilization of peptides onto the CNT channels .................. 82 
ix 
 
Figure 7.3 Electrical characteristics of peptide-based bioelectronic sensor..84 
Figure 7.4 Detection of AQP4 antibody using peptide-based bioelectronic 
sensor ...................................................................................... 86 
Figure 7.5 Detection of AQP4 antibody in human serum using peptide-based 




List of Table 




List of Abbreviations 
 
AFM: atomic force microscopy 
AQP4: aquaporin-4 
BioFET: biologically sensitive field-effect transistor 
cAMP: cyclic adenosine monophosphate 
CNS: central nerve system 
CNT: carbon nanotube 
DMEM: Dulbecco’s modified Eagle’s medium 
PBS: phosphate-buffered saline 
E. coli: Escherichia coli 
FBS: fetal bovine serum 
FET: field-effect transistor 
GC/MS: gas chromatography-mass spectroscopy 
GPCR: G protein-coupled receptor 
HEK-293: human embryonic kidney-293 
NMO: euromyelitis optica 
OR: olfactory receptor 
ORP: olfactory receptor-derived peptide 
OSN: olfactory sensory neuron 
OTS: octadecyltrichlorosilane 
PCR: polymerase chain reaction 
PDL: poly-D-lysine 
RTP1S: receptor-transporting protein 1S 
SEM: scanning electron microscope 
SD: standard deviation 
SPME : solid phase micro extraction 
TMA: trimethylamine 












Chapter 1. Research background and objective 
 
Bioelectronic sensors that integrate biology and electronics have been 
developed via multidisciplinary approaches. Biological systems in living 
organisms are operated by internal and external stimuli such as sensory 
inputs and environmental influences. Receptor proteins are used as primary 
recognition elements in signal transduction pathways, which trigger 
activation mechanisms by various stimulations. G protein-coupled receptors 
(GPCRs) are involved in various processes such as vision, olfaction, taste, 
nerve functions, metabolism and immune response.14 Receptor-ligand 
interactions modulate structural changes of the receptors and cellular 
responses such as ion influx. These changes can be utilized to develop 
biosensor using GPCRs.15 Traditionally, cell-based assays have been used 
for studying of receptor functions.16 Since most of the receptor proteins 
exist in cellular membranes, they requires in vivo-like environments for 
maintaining their functions. 
Nanomaterial-based biosensors have been emerged as a promising 
platform of bio-signal amplifications.17,18 The use of carbon nanomaterials, 
such as carbon nanotubes and graphene, has provided the significant 
advances in biomolecule sensing.19 Nanomaterial-based FET biosensors 
have strength in the size comparability and the bio-compatibility.20 The 
unique properties of nanomaterials enable the highly sensitive detection of 
biomolecule and could be applied to receptor protein researches. 
Bioelectronic sensors using receptor proteins and carbon nanotubes 
detected target molecules at single-atom resolution21, and have potential for 
various applications: food assessment, quality control, environmental and 
industrial monitoring, safety controls and medical diagnosis.22 Human 
olfactory receptors (hORs)23,24, taste receptors (TRs)25 and hormone 
receptors26 utilized for mimicking human sensory responses. The 
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integration of the human-derived receptors into bioelectronic sensor showed 
higher sensitivity than the previous sensors. 
Despite remarkable advances in bioelectronic sensor, bioelectronic 
sensors are still applied to limited areas. For the practical applications of 
receptor-based bioelectronic sensors, deorphanization of receptor proteins, 
proper functionalization strategies of nanomaterials, and multiplexing and 
miniaturization of sensing platform is required.  
In this research, artificial olfactory cells were used for screening of 
hORs which detect water contamination indicators and diabetes biomarkers. 
Olfactory nanovesicles containing the selected hORs were immobilized 
onto a CNT-FET. The nanovesicle-based bioelectronic sensor detected 
target odorants with high sensitivity and selectivity. Various kinds of ORs 
and TRs were produced in E. coli, and the reconstituted receptors were 
immobilized onto a multi-channel CNT-FET. A portable current monitoring 
system was customized with the bioelectronic sensor. Various pattern 
recognitions were successfully performed with complex mixtures. The 
protein-based multiplexed bioelectronic sensor was suitable for efficient 
assessment of food freshness. Simple and stable peptide-based bioelectronic 
sensors was applied to disease diagnosis and food quality assessment. 
 
 In summary, the objectives of this study are: 
1. Development of bioelectronic sensor using human olfactory 
nanovesicles for water quality assessment and diabetes diagnosis 
2. Development of portable and multiplexed bioelectronic sensor using 
human OR and TR proteins for assessment of food quality 
3. Development peptide-based bioelectronic sensor using ligand 
binding sites of receptors for neuromyelitis optica diagnosis and 
seafood quality assessment 
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4. Comparison of bioelectronic sensor performances with traditional 
analytical methods. 
  
In the thesis, the bioelectronic sensors using receptor proteins and CNT 
were developed. Receptor proteins were produced as nanovesicles, proteins 
and peptides, and integrated with CNT-FETs. The developed sensors were 













Chapter 2. Literature review 
 
2.1 Concept of bioelectronic sensor 
 
Technical convergence of biotechnology and nanotechnology enable 
remarkable scientific advances. Various biomolecules such as DNA, protein 
and cells were integrated with biocompatible nanomaterials.27 These 
approaches drive a deeper understanding of biological systems and 
developing novel analytical tools. Bioelectronic sensor use various kinds of 
biomolecules as primary recognition elements. Biomolecules have excellent 
specificity with their target molecules so that they overcome the limitations 
of chemical sensors.28 Electronics with carbon nanomaterials such as one-
dimensional carbon nanotubes and two-dimensional graphene layers, offer 
fast response, small, simple, and cheap transistor.29 Owing to the excellent 
properties of carbon nanomaterials, nanomaterial-based biosensors have 
been extensively developed.30,31 Especially, biologically sensitive field-
effect transistors (BioFETs) that measure biological action potentials and 
change conductivity of source-drain, have been have emerged as an 
extremely sensitive and selective sensing platforms.32,33 Following steps are 
required for the development of bioelectronic sensor; 1) production of 
suitable biomolecules for the ligand detection,34 2) stable immobilization of 
biomolecules onto an electronic sensor surface,35,36 3) conversion of 








DNA is a molecule that contains the genetic information of living 
organisms in genome sequences.37 Human genome project provide us entire 
DNA sequences and thus helps understanding gene-disease relationships.38 
Since DNA molecules are negatively charged, their interactions can be 
detected using the BioFET platform.39 The hybridization of a 
complementary DNA onto the DNA-modified FET sensor influences the 
charge density distribution of the sensor surface.40 DNA-based sensors can 
be applied to the sequencing 41and the identification of single nucleotide 
polymorphisms.42 DNA and aptamer are also utilized as primary 
recognition elements of the BioFET sensor for the detection of chemical 




Protein is a macromolecule that performs various functions in catalytic 
reactions and signal transductions. Protein 3D structures have the specific 
ligand binding sites so that the proteinsca be used as selective recognition 
elements of biosensors. Enzymes, antibodies and receptors are most 
frequently used for the development of biosensors.45 Enzyme-substrate 
reactions were applied to the glucose sensing using glucose oxidase for the 
diagnosis and management of diabetes.46 Oxygen, an additional product of 
the glucose oxidation reaction, have the reduction potentials to the FET 
sensor surface.47 Antibody-antigen interactions were applied to the cancer 
diagnosis for the detection of prostate-specific antigen (PSA).48 The specific 
binding activity of antibodies have great potentials for the development of 
novel diagnostic tools. Recently, receptor proteins that exist on the cell 
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membrane have been utilized for the development of BioFETs.49,50 Since 
receptor proteins require complex environmental conditions such as cell 
membrane structures, examples are relatively small.51 Crucial roles of 
receptor proteins in biological systems are applied to disease diagnosis, 
drug discovery and sensory stimulations. Furthermore, reprograming of 
receptor protein activity is available based on an in silico modeling of 
protein structures.52 Changes of the specific protein sequence are related to 
the selectivity of proteins. More diverse applications are expected with the 




Cell is a basic unit of organisms that is composed of many biomolecules 
such as proteins and nucleic acids. Cells can be grown on biocompatible 
nanomaterials and their activities can be measured by the BioFETs.53 
Carbon nanotubes, graphene and silicon nanowires have been reported as 
nanomaterials for cell culture matrices.54 Cell-based BioFETs provide high-
resolution observations of cellular signals, and detailed understanding of the 
biological system such as cell biology, toxicology and pharmacology. For 
examples, neuronal exon signals were monitoring using the silicon 
nanowire array55 and neuron transmitter was detected using the carbon 
nanotube transistor.56 However, cell-based sensors have limitations in their 
applications such as reliability, reusability and stability. Recently, 
monitoring of non-adherent cell activities using floating-electrode also 
reported as a reusable platform.57 Toward more scalable integration of cell 
components, cell-derived nanovesicles was also utilized for the 






2.3 Nanomaterials as secondary signal transducers 
 
2.3.1 Carbon nanotube 
 
CNTs are one-dimensional nanomaterials that made from one layers of 
graphite. CNTs have unique structural, electronic and chemical properties 
that are useful for biosensing applications.58 CNTs are divided into two 
types: single-walled nanotubes (SWCNTs) made of a single carbon layer, 
and multi-walled nanotubes (MWCNTs) made of several nested tubes. 
Large-scale fabrication techniques for CNTs are developed using linker-free 
directed assembly, and it is expected to lead to the mass production of 
bioselectronic sensors.59 The surface of CNTs can be covalently modified 
using pi-interactions,60 and non-covalently modified using hydrophobic 
interactions.61 These strategies offer opportunities for the immobilization of 
various biomolecules. CNTs have p-type FET characteristics and current 





Figure 2.1 A sensing principle of CTN-FET. CNT-FETs have p-type 
properties and hole charge carriers are dominant in the current flow. The 




2.3.2 Conducting polymer 
 
Conducting polymers are organic polymers that have the electrical 
conductivity, and their properties for biosensing applications can be 
controlled by a doping/dedoping process.62 Large surface area and porous 
structures of conducting polymers are regarded as advantages for rapid 
biosensing platforms.63 Polyaniline (PANI), polypyrrole (PPy), 
polyacetylene (PAc), polyphenylene(PPP) and polythiophene (PT) are 
commonly used for the development of the biosensors.64 Physical 
adsorption,65 entrapment,66 cross-linking67 and covalent bonding68 have 
been used for the biomolecule immobilization onto conducting polymers. 
Furthermore, conducting polymer hydrogels (CPHs) that combine 
hydrogels and organic conductors, provide high water contents and 3D 




Graphene is a two-dimensional material form of carbon that have 
unique physicochemical properties for such as high surface area, excellent 
conductivity, high mechanical strength, and ease of functionalization.71 
Graphene can be easily produced by the peeling-off methods72 and chemical 
vapor deposition (CVD) methods can produce large areas of a single layer 
graphene.73 Graphene-based biosensor was sufficiently biocompatible to be 
used for in vitro and in vivo monitoring.74 Furthermore, the hybrid 
structures of polymers and graphene improve the performances and expand 
their applications.75 The ability to modulate the properties of graphene-
based sensor means that is able to develop a sensor that can operate in 
desired conditions. Flexible graphene-based capacitors have been developed 
with the laser scribing method.76 It is expected to develop wearable devices 




2.4 Bioelectronic sensors using receptor proteins 
 
2.4.1 Bioelectronic nose 
 
Bioelectronic noses that use human olfactory receptors as primary 
recognition elements and nanomaterials as secondary transducers have been 
reported.77 In the human nose, odor molecules binds to olfactory receptors 
in olfactory sensory neurons of the olfactory epithelium.78,79 The activated 
neurons deliver electrical signals to the glomerulus and the signals are 
transmitted to the higher regions of the brain.80 Humans have approximately 
400 functional olfactory receptors and combinatorial odor binding patterns 
of the receptors could discriminate more than 10,000 different odors.81,82,83 
In the bioelectronic nose platform, human olfactory receptors selectively 
distinguish target ligands with a single atomic resolution like human nose 
do,84 and their electric potential changes are converted into a field effect of 
the transistor sensor.85 The transistor circuit based on the nanomaterials, 
such as carbon nanotubes,86 graphene87 and conducting polymers,88 rapidly 
and sensitively amplify the biological signals. Advantages of the specific 
odor binding of the olfactory receptor and rapid signal transduction of 
nanomaterials have been used in various applications. Bioelectronic noses 
detect potential biomarkers such as heptanal (a serum biomarker of lung 
cancer) for disease diagnosis,89 geosmin and 2-methylisoborneol (water 
contamination indicatiors) for environmental and industrial monitoring,90 
hexanal (a lipid oxidation indicator),91 trimethylamine (a seafood 
decomposition indicator)92,93 and 1-octen-3-ol (a fungal contamination 
indicator of grain)94 for food quality assessment. Bioelectronic nose rapidly 
detects target molecules with simple manipulations compared with the 
conventional methods that require complex pretreatment and large 
instruments. The miniaturized platforms with the bioelectronics enable 
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portable sensing systems for on-site analysis of odor compounds. 
Furthermore, the human olfactory receptor-based bioelectronic nose that 
mimics the human smell sensing mechanism indicates the complex pattern 
recognition of the olfactory system with the multiplexed platform.95 The 
multiplexed bioelectronic nose is composed of various human olfactory 
receptors in the sensor array networks and quantify the response of 
stimulated olfactory receptor signals. The sensor array networks combine 
olfactory signals like olfactory sensory neurons do in the human nose96 and 
computer process define the olfactory code like the human brain. 
 
2.4.2 Bioelectronic tongue 
 
Bioelectronic tongue that combines human taste receptors and -
electronics, mimics the human taste systems and their various applications 
have been reported.50 Humans are known to have the five basic tastes; sweet, 
sour. Bitter, salty and umami.97 In the human tongue, tastants are 
recognized by different cells expressing specific taste receptors. There are 
two opinions for the taste quality coding; labelled-line model98 and across-
fibre models.99 GPCRs for umami, sweet and bitter are previously identified; 
umami: T1R1+T1R3 heterodimer,100 sweet: T1R2+T1R3 heterodimer,101 
and bitter: about 30 T2Rs.102,103 These receptors are utilized for the 
development of biolectronic nose and their human-like performances were 
evaluated. CNT-FET using human bitter receptor protein,104 CNT-FET 
using human sweet receptor nanovesicle,25 CPNT-FET using human bitter 
taste receptor protein,105 and CNT-FET using insect umami nanovesicle106 





Various applications of bioeletronic sensors using receptors have been 
reported (Table 2.1). A chemical-pain sensor is constructed with rat pain 
sensory receptor rTRPV1 and nanovesicle-based CNT-FET.107 The 
chemical-pain sensor detects capsaicin with a high sensitivity and expected 
to be utilized for drug screening systems. A disease specific antibody sensor 
is constructed with aquaporin-4 and nanovesicle-based CNT-FET.108 The 
antibody sensor detects AQP-IgG and related biomedical applications such 
as disease diagnostics. A dopamine biosensor is constructed with human 
dopamine receptor nanovesicles and conducting polymer nanomaterials.109 
The dopamine sensor can be applied to the diagnosis of Parkinson’s disease. 
A hormone biosensor is constructed with human parathyroid hormone 
receptor and carboxylated polypyrrole nanoparticles.110 The peptide 
hormone sensor can be applied to analyze hormone imbalance in human 
body. For the development of applicable sensors in various fields, the 
produced receptor proteins should be functional and stable. In addition, the 
proper immobilization steps onto nanomaterials are required according to 









Receptor Ligand Application Reference 
Nanovesicle 
 
CNT hOR1J2 Heptanal Lung cancer diagnosis 89 
CNT cfOR5269 Hexanal Lipid oxidation in dairy products 92 
CNT hOR8H2 1-octen-3-ol Fungal contamination in grain 94 
CNT hTAS1R2, hTAS1R3 Sucrose Sweet taste analysis 25 
CNT AmGr10 MSG Umami taste analysis 106 
CNT rTRPV1 Capsaicin Chemical pain analysis 107 
CNT Aquaporin 4 AQP4-IgG NMO diagnosis 108 
CPEDOT hDRD1 Dopamine Parkinson disease diagnosis 109 
Protein CNT hTAS2R38 PTC, PROP Bitter taste analysis 105 
CNT M1 mAChR Acetylcholine Neurotransmitter analysis 26 
Peptide 
 
CPPyNPs hPTHR hPTHR Hormone imbalance analysis 110 













Chapter 3. Experimental procedures 
 
3.1 Gene cloning 
 
All receptor genes were amplified by polymerase chain reaction from 
human genomic libraries. Human ORs were cloned with sequence 
information from the Olfactory Receptor DataBase. All hORs were 
subcloned in pcDNA3 mammalian expression vectors (Invitrogen, USA) 
containing the first 20 amino acids of human rhodopsin (Rho-tag) (Zhuang 
and Matsunami, 2007). Human OR2J2, 2W1, TAAR5, and TAS2R38 were 
cloned in the pET-DEST42 E. coli expression vector (Invitrogen, USA) 
containing a 6xHis-tag. The sequences of the cloned genes were verified by 
sequencing (GenoTech, Korea). 
 
3.2 Production of receptor proteins 
 
3.2.1 Mammalian expression 
 
Human embryonic kidney (HEK)-293 cells were cultured in Dulbecco’s 
Modified Eagles Medium (DMEM) (HyClone, USA) supplemented with 10% 
Fetal Bovine Serum (FBS) (Gibco, USA) and 100 U/ml penicillin, 100 
μg/ml streptomycin (Gibco, USA) at 37°C and 5% CO2. Transfection was 
performed with the Neon Transfection System (Invitrogen, USA). The cells 
were harvested and resuspended in phosphate-buffered saline (PBS) and 2 x 
106 cells were mixed with 5 μg of OR, 2 μg of pCRE-Luc, 1 μg of pSV40-
RL, 1 μg of RTP1S, 0.5 μg of Ric8b, 0.5 μg of Gαolf. Electric pulses were 
then applied three times at 1100 V with 10 ms per pulse. Transfected cells 
were cultured in DMEM supplemented with 10% FBS without antibiotics, 





3.2.2 Bacterial expression 
 
The BL21(DE3) E. coli was transformed and incubated in LB medium 
containing 100 µg/ml ampicillin at 37°C. The expression of the receptor 
proteins was induced at 0.5 OD600 with 0.5 mM IPTG, and incubated for 4 h. 
The cells were harvested by centrifugation (4°C, 7,000 g, 30 min) and 
resuspended in PBS containing protease inhibitors. The resuspended cells 
were lysed by sonication with 5 s on/off for 10 min (Sonics Vibracell, 
USA), and the lysates were solubilized in 0.1 M Tris-HCl (pH 8.0), 20 mM 
SDS, 1 mM EDTA, and 100 mM DTT at room temperature. The solubilized 
proteins were dialyzed in 0.1 M sodium phosphate and 10 mM SDS buffer 
(pH 8.0) with a 10K MWCO membrane (Thermo Scientific, USA), and 
filtered through a 0.2 µm syringe filter (Pall Life Sciences, USA). The 
proteins were then purified by a His6 Ni gravity column (Clonetech 
Laboratories, USA), and equilibrated with 0.1 M sodium phosphate and 10 
mM SDS (pH 8.0), washed with 0.1 M sodium phosphate and 10 mM SDS 
(pH 8.0 and then pH 7.0), and eluted from the column with pH 6.0. The 
eluted proteins were dialyzed in 0.1 M Tris-HCl, 10 mM SDS, 0.5 mM 
EDTA (pH 8.0) and 0.1 M Tris-HCl, 3 mM SDS, 0.5 mM EDTA (pH 8.0). 
For the reconstitution of receptors, 1 mM GSSG, 6 mM GSH, 6 mM DDM, 
6 mM Cymal 6, and 6 mM MβCD were added, and the solution was stored 
at -20°C for 48 h. The samples were thawed at 4 °C and 25 mM CaCl2 was 
added. Finally, the samples were dialyzed in 100 mM Tris-HCl, 300 mM 
NaCl, 10% glycerol, 1 mM DDM, 1 mM Cymal 6, and 1 mM EDTA (pH 
7.4). The secondary structure of the reconstituted protein samples was 
analyzed using a CD spectrometer (Applied Photophysics, UK) at 
wavelengths between 200 and 250 nm. Their functionality was analyzed by 
a tryptophan fluorescence quenching method using a luminescence 




3.2.3 Construction of nanovesicles 
 
HEK-293 cells were resuspended in serum-free DMEM containing 10 
μg/ml of cytochalasin B (Sigma, USA) and agitated at 300 rpm for 30 min. 
The nanovesicles were separated from the cells by centrifugation at 500 g 
for 10 min, and the supernatant was centrifugated to collect the 
nanovesicles at 15000 g for 30 min. The produced nanovesicles were 
resuspended in PBS with 1 μg/ml of total protein concentration, stored at -
70°C, and melted before being use. 
 
3.2.4 Synthesis of peptides 
 
Human olfactory receptor-derived peptide (horp61m: 
NQLSNLSFSDLFFF) and three kinds of AQP4 extracellular loop peptides 
(A : GGSENPLPVFFF, C : TPPSVVGGLGVTTVHGNLTAGFFF, E : 
GNWENHWFFF) with purity higher than 95% were purchased from 
Peptron (Korea). All peptides were dissolved and diluted at 1 mg/ml with 
distilled water. The diluted peptide solution was stored at -20°C and thawed 
before used. 
 
3.3 Characterization of receptor proteins 
 
3.3.1 CRE-Luciferase reporter gene assay 
 
The Dual-Glo Luciferase Assay System (Promega, USA) was used to 
measure receptor response. Approximately 24 hours after transfection, the 
medium was replaced with 50 μl of DMEM and incubated for 30 min at 
37°C. After stimulation with 25 μl of odorants for 4 hours at 37°C, 
luminescence was measured with Luminoskan Ascent Microplate 
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Luminometer (Thermo Scientific, USA). The luciferase activity was 
normalized with the formula [CRE/Renilla(N) – 
CRE/Renilla(0)]/[CRE/Renilla(FSK) – CRE/Renilla(0)]. 1 μM forskolin 
(FSK), an adenylyl cyclase activator, was used as a positive control and a 
no-odorant solution was used as a negative control for each hOR. 
 
3.3.2 Calcium influx assay 
 
HEK-293 cells were incubated for 30 min with 10 μM of Fura-2 AM 
(Invitrogen, USA) in Ringer’s solution (140 mM NaCl, 1 mM MgCl2, 1.8 
mM CaCl2, 5 mM KCl, 5 mM glucose, 10 mM HEPES (pH 7.4)) at 37°C. 
The Fura-2 AM-loaded nanovesicles were produced as described for the 
formation of regular nanovesicles and placed on a 96-well plate. Calcium-
dependent fluorescence was measured at 510 nm with dual excitations at 





HEK-293 cells were fixed with 4% paraformaldehyde in PBS at room 
temperature for 20 min. The cells were blocked with 5% BSA diluted in 
PBS and incubated with the Rho-tag antibody at a 1:500 dilution in PBS 
with 5% BSA at 37°C for 1hour. The cells were then washed three times 
with PBS and incubated with the Alexa Fluor 594 (Invitrogen, USA) at 
1:1000 dilution in PBS with 5% BSA at 37°C for 1hour. 
 
3.3.4 Western blot analysis 
 
HEK-293 cells and nanovesicles were washed twice with PBS and lysed 
by sonication (2s on/off, 5 min). The supernatant and membrane fractions 
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were separated by centrifugation at 15000 g for 30 min. Protein samples 
were loaded onto 10% SDS-PAGE gels and transferred to PVDF 
membranes (Bio-Rad, USA) under 0.15 A of constant current for 60 min. 
The membranes were blocked with 5% BSA diluted in PBS and 0.1% 
Tween-20 at room temperature for 1 hour and incubated overnight with the 
Rho-tag antibody at a 1:1000 dilution in PBS with 5% BSA and 0.1% 
Tween-20 at 4°C. The membranes were then washed three times for 5 min 
with PBS with 5% BSA and 0.1% Tween-20 and incubated with anti-rabbit 
IgG-HRP (Invitrogen, USA) at 1:1000 dilution in PBS with 5% BSA and 
0.1% Tween-20 at room temperature for 1 hour. ECL solution (Thermo 
Scientific, USA) was used to detect proteins expressed on the membrane. 
 
3.3.5 Scanning electron microscopy 
 
HEK-293 cell-derived nanovesicles were applied on poly-D-lysine-
coated slide glass and fixed with 4% paraformaldehyde in PBS at room 
temperature for 20 min. The fixed nanovesicles were dehydrated with 
increasing concentrations of ethanol and lyophilized by freeze-drying. The 
lyophilized nanovesicles were coated with Pt (10nm) by a sputtering 
method and visualized by SEM. 
 
3.4 Construction of in vitro disease models 
 
3.4.1 Cultivation of adipocytes and skeletal muscle cells 
 
Pre-adipocytes 3T3-L1 were maintained in DMEM (Hyclone, USA) 
supplemented with 10% calf serum (Gibco, USA), and differentiated into 
adipocytes with a DMI medium (DMEM, 10% FBS (Gibco, USA), 500 μM 
IBMX, 5 μg/ml insulin, 250 nM dexamethasone). The differentiation 
medium was removed after 2 days and replaced with DMEM supplemented 
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with 10% FBS and 1 μg/ml insulin. The medium was replaced every 2 days 
with DMEM supplemented with 10% FBS, 10-12 days post differentiation. 
Myoblasts L6 were maintained in DMEM supplemented with 10% FBS, 
and differentiated into skeletal muscle cells with DMEM containing 2% 
horse serum, 5-7 days post differentiation. 
 
3.4.2 2-Deoxyglucose uptake assay 
 
Glucose Uptake Cell-Based Assay Kit (Cayman Chemical, USA) was 
used to analyze the glucose uptake activity of the cells. The differentiated 
cells were serum-starved for 12 hours in DMEM containing 0.2% BSA. The 
cells were cultured for 24 hours in DMEM containing 0.5 mM palmitic acid. 
After washing two times with PBS, the cells were incubated with KRB 
ringer’s solution containing 100 nM insulin for 30 min (adipocytes) and 60 
min (skeletal muscle cells) at 37°C. Then, the cells were incubated with 
KRB ringer’s solution containing 150 μg/ml 2-NBDG for 10 min at at 37°C. 
The incubated cells were washed two times with PBS and fluorescence was 
measured at 535 nm with excitation at 485 nm using a GENios Pro 
microplate reader (TECAN, Switzerland). 
 
3.4.3 GC/MS analysis 
 
The volatile organic compounds (VOCs) in the headspace of the cells 
were analyzed using Trace GC Ultra gas chromatography (Thermo 
Scientific, USA) with an ITQ1100 mass spectrometer (Thermo Scientific, 
USA). Before experiments the cell culture medium was replaced with the 
fresh DMEM, and 65 μm PDMS/DVB-coated SPME fiber (Supelco, USA) 
was placed on the headspace. The fiber was incubated for 16 hours at 37°C, 
and injected to the GC/MS. The inlet temperature was 250°C. The column 
temperature was maintained at 40°C for 4 min and increased to 230°C at the 
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rate of 5°C/min, and maintained for 4 min. The temperatures of the ion 
source and the mass transfer line were 260°C and 285°C, respectively. The 
detected VOCs were identified by the NIST library. 
 
3.5 Fabrication of bioelectronic sensor 
 
3.5.1 Fabrication of CNT-FET 
 
Purified swCNTs (Hanwha, Korea) were dispersed in 1,2-
dichlorobenzene solution by applying ultrasonic vibration for 1 hour. To 
create swCNTs patterns on a silicon oxide wafer, the 
octadecyltrichlorosilane (OTS) self-assembled monolayer (SAM) technique 
was used. First, we patterned AZ5214 photoresists on a silicon oxide wafer 
by using a conventional photolithographic technique. Then the wafer was 
placed in an OTS solution (1:500, v/v in hexane) for 5 min to create OTS 
SAM on the wafer. Subsequently, the OTS-coated wafer was dipped in 
acetone to remove the AZ5214 patterns. Next, the OTS-patterned wafer was 
placed in the swCNT solution for 30 s. These steps allowed swCNTs to be 
adsorbed selectively onto bare silicon oxide regions in the wafer, while 
OTS SAM regions blocked the adsorption of swCNTs. Source and drain 
electrodes (Au/Pd, 30 nm/10 nm) were fabricated via conventional 
photolithography, thermal evaporation, and lift-off process. Finally, the 
source and drain electrodes were passivated with a photoresist to prevent 
current leakage from the electrodes. 
 
3.5.2 Fabrication of multi-channel CNT-FET 
 
A silicon oxide substrate was patterned for swCNT assembly. The 
patterned SiO2 (300nm) wafer was placed in the OTS solution (OTS: 
Hexane = 1 : 400) for 7 min to form a self-assembled monolayer of OTS, so 
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that the OTS patterned regions were non-polar. The OTS patterned wafer 
was placed in the swCNT (Sigma Aldrich, USA) solution (0.02mg/ml in 
1,2-dichlotobenzene) for 30 s and rinsed thoroughly with 1,2-
dichlotobenzene. swCNT was selectively absorbed on the empty SiO2 
regions due to the self-assembled OTS layer. Subsequently, the Ti/Au 
(100/300 nm) electrodes were developed via a thermal evaporation method. 
Finally, the passivation layers were fabricated on the electrode regions to 
prevent leakage currents of during the experiments under aquatic conditions. 
swCNTs of the MCS (multi-channel sensor) were functionalized with 
nickel ions following a previously reported method. The MCS was placed 
in 10 mM 4-carboxybenzene diazonium tetrafluoroborate solution at 45 °C 
for 1 h, followed by washing with acetone, methanol, and water. An 
activation buffer was prepared with 0.1 M 2-(N-morpholino)ethanesulfonic 
acid sodium salt (MES) and 0.5 M NaCl (pH 6.0 adjusted with HCl). The 
MCS was placed in 2 mM EDC and 5 mM Sulfo-NHS in the activation 
buffer at room temperature for 15 min, in order to activate the carboxylic 
acid of 4-carboxybenzene diazonium tetrafluoroborate. The MCS was then 
washed with activation buffer and placed in 11.3 mM NTA-NH2 in PBS 
solution for 2 h. Subsequently, the MCS was washed with DI water and 
placed in 11.3 mM NiCl2 for 1 h. Upon completion, the MCS was 
thoroughly washed with DI water and dried with N2. 
 
3.5.3 Immobilization of nanovesicle 
 
For the immobilization of nanovesicsles, 0.1 mg/ml of poly-D-lysine in 
PBS was added to CNT channel regions and incubated at room temperature 
for 2 hours. Then, 1 μl of nanovesicles in PBS was added to the swCNT 
channel and the mixture was incubated at 4°C for 2 h. Nanovisicles 





3.5.4 Immobilization of protein 
 
For the direct immobilization of His-fused receptor proteins onto Ni-
decorated CNT channels, 1 µM reconstituted protein was placed on each 
channels for 30 min at 4°C. Receptor proteins were immobilized onto CNT 
channels using His-Ni interactions. 
 
3.5.4 Immobilization of peptide 
 
For the immobilization the receptor-derived peptides, 1 µg/µl of peptide 
solution was placed on the CNT channel of the fabricated CNT-FET for 4 h. 
After immobilization, unbound peptides were washed 3 times with distilled 
water. Phe-modified Peptides were immobilized CNT channels using pi-pi 
interactions. 
 
3.5.5 Characterization of nanovesicle immobilization 
using SEM 
 
Nanovesicles on CNT channels were fixed with 4% paraformaldehyde 
in PBS at room temperature for 20 min. The fixed nanovesicles were 
dehydrated with increasing concentrations of ethanol and lyophilized by 
freeze-drying. The lyophilized nanovesicles were coated with Pt (10nm) by 
a sputtering method and visualized by SEM. 
 
3.5.6 Characterization of receptor and peptide 
immobilization using AFM 
 
The imaging of CNT channels were performed using AFM 
(Asylum Research, USA) under ambient conditions. At first, the 
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pristine CNT channels were imaged in tapping mode with a scan rate 
of 0.2 Hz. After the immobilization of the proteins and peptides, 
AFM imaging of the CNT channels was performed in the same mode 
at 0.1 Hz to avoid undesired noise. 
 
3.6 Electrical measurement 
 
3.6.1 Single-channel CNT-FET 
 
For the electrical signal measurement, 20 µl of PBS with pH 7.4 was added 
to the CNT channel. A 0.1 V bias voltage was applied between the source-
drain electrodes, while the gate voltage was grounded. Current changes 
were monitored with a 2636A Dual-channel system source meter 
instrument (Keithley, USA) and a MST 8000 probestation (MS TECH, 
Korea). 
 
3.6.2 Multi-channel CNT-FET 
 
For the simultaneous detection of four individual channels for one set, 49.5 
µl PBS buffer was placed on the multi-type CNT channels and 0.5 µl 
standard molecules or food samples were injected into the sensor. After 30 s, 
the current signals of each channel were monitored using the 
HyperTerminal software. All standard molecules were serially diluted 1:10 
using PBS and stored at 4°C until used. All foods; banana (Philippines), 
beef sirloin (Australia), broccoli (Korea), cabbage (Korea), sliced cheese 
(Korea), chicken breast (Korea), milk (Korea), oyster (Korea), pork sirloin 
(Korea), potato (Korea), white leg shrimp (Iran), and strawberry (Korea) 
were purchased from a local market and stored at 4°C. For the preparation 
of food samples, 1 ml PBS buffer was added to 1 mg food, and their liquid 
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Chapter 4. Development of bioelectronic sensor using 
human olfactory nanovesicles for the detection of odor 




Water is one of the most important resources for biological systems, not 
only for human being but also for all known living organisms. With 
growing interest in environmental pollution, water contamination has 
emerged as an important issue. When water is contaminated by bacteria, 
various off-flavors are produced such as geosmin (GSM) and 2-
methylisoborneol (MIB), which release an earthy and musty odor, 
respectively.111,112,113 A human nose is extremely sensitive to these 
molecules114 and these compounds are regulated by law for safe drinking 
water. In addition, harmful algal bloom, which occurs with high bacterial 
densities and increased water temperature, can be recognized by the smells 
of GSM and MIB.115 
Typically, solid-phase microextraction gas chromatography-mass 
spectrometry (SPME-GC/MS) is used for the detection of GSM and MIB in 
water supply system.116,117 Although conventional methods have the 
advantage of a quantitative component analysis, they have limitations in 
rapid on-site assessments of water quality due to their long and complex 
pretreatment procedures, and large-sized instrumentations. Additionally, the 
equipment is too complicated for beginners, and requires expert operators. 
Recently, the bioelectronic nose, which integrates of olfactory receptors 
(ORs) found in natural system and nanomaterials such as carbon 
nanotube,24,84,86,89,91,92,118 conducting polymer88 and graphene87, has been 
reported as an effective analytical tool for detecting various volatile organic 
compounds with high selectivity and sensitivity22,77. 
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Herein, we report a human olfactory receptor (hOR)-based bioelectronic 
nose that mimics the human smell sensing mechanism for the fast and easy 
assessment of water quality by detecting GSM and MIB. The bioelectronic 
nose is composed of single-walled carbon nanotube (swCNT) field-effect 
transistor (FET) functionalized with hOR expressing cell-derived 
nanovesicles. We demonstrate that this bioelectronic nose can serve as a 
sensor to monitor water quality in real time and even on the spot by directly 
detecting water contaminants without complex pretreatment processes. 
 
4.2 Screening of human olfactory receptors 
 
In human olfactory senses, numerous smells are recognized by the 
binding pattern of the odorants with hORs in olfactory sensory neurons.81,119 
The majority of the hOR to ligand binding patterns are unknown and 
extensive efforts to deorphanize the hOR ligands were undertaken using 
various methods. To identify the specific receptors for the recognition of 
GSM and MIB, we constructed libraries comprising of 193 different 
olfactory receptors representing around 50% of the total hORs and cAMP 
response element (CRE)-luciferase reporter gene assay was performed with 
human embryonic kidney (HEK)-293 cells expressing 193 kinds of 
hORs.8,120 In the primary screening, we stimulated each hOR with 1 mg/l of 
odorants in triplicate, and the receptors that responded were selected for a 
secondary screen (Figure 4.1(a)). Then, the specificity of the selected hORs 
was identified by applying five standard odorants of drinking water: GSM, 
MIB, 2,4,6-Trichloroanisole (TCA), 2-Isopropyl-3-methoxypyrazine (IPMP) 
and 2-Isobutyl-3-methoxypyrazine (IBMP). Based on the results, hOR51S1 
and hOR3A4 were selected as specific receptors for GSM and MIB, 
respectively (Figure 4.1(b)). Furthermore, the successful expression of 
hORs in the cell membrane was confirmed by immunocytochemistry 




Figure 4.1 Screening of human olfactory receptors. (a) Responses of 193 
human olfactory receptors to 1 μg/ml of GSM and MIB. (b) Selectivity of 
hOR3A4 and hOR51S1. The experiments were performed using 1 μg/ml of 
5 drinking water odor standards. Error bars, s. e. m. three replicates. * P < 






Figure 4.2 Expression of human olfactory receptors in mammalian cells. (a) 
Immunocytochemistry of hOR3A4 and hOR51S1 expressed in HEK-293 
cell surface. (b) Western blot analysis of hOR3A4 and hOR51S1 expressed 






4.3 Characterization of olfactory nanovesicles 
 
Due to their large size and unstability, mammalian cells are not suitable 
for the functionalization of nanomaterials such as carbon nanotubes. To 
solve this problem, nanovesicles were produced from HEK-293 cells 
expressing either hOR3A4 or hOR51S1 by treatment with cytochalasin B, 
an agent that destabilizes cytoskeleton-membrane interactions.9 
Nanovesicles were released from cytochalasin-treated cells by 300 rpm 
agitation and collected by sequential centrifugation. The produced olfactory 
nanovesicles had a sphere-like appearance (Figure 4.3(a)) and their 
diameters were approximately 100 nm (Figure 4.3(b)). The presence of 
olfactory receptors in the nanovesicles was confirmed by Western blot 
analysis (Figure 4.3(c)). Human ORs in the nanovesicles were observed at 
the expected molecular weight size, whereas no band was observed with 
control cell-derived nanovesicles. Olfactory receptor activity in the 
nanovesicles was confirmed by calcium assay with calcium ion-selective 
fluorescent dye (Figure 4.3(d)). With only hORs in the nanovesicles, the 
fluorescence signal increased after injection with 100 mg/l of odorants. 
Furthermore, mass production of the olfactory nanovesicles was possible 
and they are reported to be stored at -70°C for several weeks without loss of 
their functional activity.9 These results indicated that the hORs and their 
activities were both maintained in nanovesicles and hORs could be used for 




Figure 4.3 Characterization of olfactory nanovesicles (a) SEM image of 
nanovesicles. (b) Measurement of size distributions via electrophoretic light 
scattering. (c) Western blot analysis of hOR3A4 and hOR51S1 in 
nanovesicles. (d) Calcium ion influx assay of nanovesicles with the addition 




4.4 Construction of nanovesicle-based bioelectronic nose  
 
The swCNT surface was treated with positively charged poly-D-lysine 
(PDL) and functionalized with the olfactory nanovesicles using a charge-
charge interaction caused by negatively charged nanovesicle membranes 
(Figure 4.4(a)). The bioelectronic nose is designed to contain two channels 
for the simultaneous detection of GSM and MIB. And each channel is 
functionalized with nanovesicles carrying hOR3A4 and hOR51S1, 
respectively (Figure 4.4(b)). As a result, the bioelectronic nose can detect 
GSM and MIB simultaneously. When the bioelectronic nose is exposed to 
odorants, the binding between ORs and odorants induce a signal 
transduction with human smell sensing mechanism. This signal transduction 
results in the influx of Ca2+ ion into the nanovesicles and gives a field effect 
on the swCNT-FET. Successful immobilization of nanovesicles on the 
swCNT channel was confirmed by SEM image (Figure 4.4(c)). Source-
drain current-voltage (ISD-VSD) characteristics for each of the channels were 
measured to identify the electrical properties of the bioelectronic nose 
(Figure 4.4 (d)). The observed curves were linear over a voltage range from 
-0.4 V to +0.4 V, showing the stable ohmic behavior of the swCNTs before 
and after the functionalization with olfactory nanovesicles in both channels. 
Although the dI/dV values decreased after the functionalization of the 
swCNTs due to the increasing resistance, the linearity of the ISD-VSD curve 
was maintained. We constructed a liquid-ion gated FET system with PBS 
(pH 7.4) as the electrolyte. The source-drain currents of both channels 
decreased with an increasing gate voltage before and after immobilization 
of the olfactory nanovesicles, indicating p-type behavior in both channels 
(Figure 4.4(e)). These electrical characteristics indicate that the 






Figure 4.4 Characterization of nanovesicle-based bioelectronic nose. (a) 
Schematic diagram showing the structure of a bioelectronic nose. (b) 
Optical image of a bioelectronic nose. CNT channels are indicated by black 
arrows. (c) SEM images of CNT channels functionalized with olfactory 
nanovesicles. (d) Current-voltage (ISD-VSD) curves of each channel before 
and after the functionalization of olfactory nanovesicles. (e) Gating curves 




4.5 Detection of GSM and MIB using bioelectronic nose 
 
Figure 4.5(a) shows the real-time conductance measurement of the 
bioelectronic nose with different concentrations of odorants ranging from 
100 pg/l to 100 μg/l. Each olfactory receptor showed dose-dependent 
responses to its specific ligand and the limit of detection (LOD) was 10 ng/l, 
which is sufficiently low level for water quality monitoring.112 The RSD 
value for 10 ng/l GSM was calculated as 50.04% and 42.54% for 10 ng/l 
MIB (n = 3). There was no significant change after treatment with both 
odorants at 100 μg L-1. This is attributed to the saturation of calcium ions 
and depletion of components for signaling within the olfactory 
nanovesicles.121 The conductance change was normalized by its maximum 
response to calculate the sensitivity of the bioelectronic nose. Figure 4.5(b) 
shows the graph for the normalized sensitivity of the bioelectronic nose at 
different concentrations of odorants before and after functionalization of the 
olfactory nanovesicles. The dose-dependent responses of bioelecronic nose 
were analyzed by using the Langmuir isotherm model as previously 
reported.24 The calculated equilibrium constant Kd was 3.89 x 108 M-1 with 
GSM and 4.00 x 108 M-1 with MIB. When nanovesicles derived from the 
control cells without olfactory receptors were used, no signal was observed 
(Figure 4.6). In a sensing system, it is very important that the sensor 
discriminates only the target ligand from a complex mixture. Figure 4.5(c) 
shows that the bioelectronic nose distinguishes GSM and MIB from other 
drinking water odor standards, even though much higher concentrations of 
control compounds were applied (Figure 4.7). To evaluate the role of 
calcium ions in this sensing system, the same experiments were carried out 
with calcium ion-free PBS buffer used as an electrolyte and no signal was 
observed. Furthermore, when the calcium ion channel was blocked with 
MgCl2, the bioelectronic nose showed no responses (Figure 4(d), Figure 
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4.8). These results indicate that calcium flux into the nanovesicle caused a 





Figure 4.5 Detection of GSM and MIB using bioelectronic nose. (a) Real-
time responses of bioelectronic nose to the injection of various 
concentrations of odorants. (b) Dose-dependent response curves of 
bioelectronic nose with GSM and MIB. Error bars, s. e. m. three replicates. 
(c) Selective responses of bioelectronic nose to GSM and MIB. (d) Effect of 





Figure 4.6 Real-time response of bioelectronic nose to each odorant 





Figure 4.7 Selectivity of bioelectronic nose. (a) Selective recognition of 







Figure 4.8 Effect of ion channel blocker and calcium ion on the 
bioelectronic nose. (a) Real-time response of bioelectronic nose to their 
specific ligand with 10 mM of MgCl2, ion channel blocker and (b) without 




4.6 Detection of GSM and MIB from water samples 
 
Water samples containing GSM and MIB were examined to evaluate 
whether the bioelectronic nose can be used for on-site and real-time 
measurement of water contamination (Figure 4.9). Each of the odorants was 
added to laboratory tap water, commercial bottled water (Evian, France) 
and river water at a concentration of 20 ng/l. The bioelectronic nose did not 
respond to the negative control for odorant samples, but the current signal 
decreased when their ligands were present in the water samples. These 
results indicate that the bioelectronic nose can discriminate a target ligand 
from water samples containing a complex mixture, and thus it can be used 




Figure 4.9 Detection of GSM and MIB from water samples. (a) Real-time 








To overcome the limitations of conventional methods for rapid on-site 
assessment of water contamination, a bioelectronic nose was developed 
using human olfactory nanovesicle-functionalized swCNT-FET that mimic 
the human smell sensing mechanism. For the selective recognition of odor-
causing molecules from contaminated water, hOR51S1 and hOR3A4 were 
selected as specific receptors for GSM and MIB, respectively. Olfactory 
nanovesicles, which were produced from mammalian cells expressing the 
selected hORs on the cell surface, were immobilized on swCNTs for 
sensitive and selective detection. The detection limit of the bioelectronic 
nose was at a sufficiently low level for the detection of GSM and MIB in 
water, supporting the application of this sensor in the assessment of water 
quality. And the simultaneous measurement of two odorants was available 
with the bioelectronic nose. Moreover, the odorants were detected in 
various water samples without any pre-treatment. These results clearly 
show that this bioelectronic nose will be suitable for the rapid and facile 
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Chapter 5. Development of bioelectronic sensor using 
human olfactory nanovesicles for the detection of VOCs 




Type 2 diabetes is a severe metabolic disease which is characterized by 
insulin resistance, hyperglycemia, and dyslipidemia.122 Early and exact 
diagnosis of diabetes is an important issue to prevent patients from serious 
complications such as cardiovascular disease, respiratory infection. 
Recently, various VOCs related to several cancers were identified with 
specific cells and tissues, and these VOCs were considered as biomarkers of 
cancers123,124,125 and also there have been many efforts to develop the 
sensing system for detecting VOCs. Several studies have reported that 
insulin resistance in skeletal muscle and adipose tissue was induced by 
lipid- and fat-derived free fatty acids.126,127 High level of free fatty acids 
induced inflammation resulting in glucose tolerance in muscle, heart and 
adipose tissue.128,129 It is very difficult to find out biomarkers of severe 
diseases directly from patients although many researchers have tried to it, 
because there are needs for identical samples from many patients and this 
process is expensive, labor-intensive, and time-consuming. These 
difficulties can be overcome by the identification of biomarkers from in 
vitro disease cell system. Here, we identified VOCs related to diabetes 
using in vitro insulin resistant model system and developed the 




5.2 Construction of in vitro diabetes models 
  
For the construction of in vitro diabetes models, mouse adipocytes 
(3T3-L1) and rat skeletal muscle cells (L6) were differentiated with the 
stimulation medium and insulin resistances were generated by the exposure 
to palmitic acid. Figure 5.1 (a) shows fluorescence images of glucose 
uptake levels of diabetes model cells. The fluorescent intensities were 
increased with the addition of insulin in both cells and the increased levels 
were returned with the addition of palmitic acid. Figure 5.1(b) shows the 
quantitative comparison of the glucose uptake levels. These results meant 
the constructed in vitro models had the characteristics of the early-phase 
diabetes models in which insulin resistance induced by free fatty acids. 
SPME-GC/MS was used for the analysis of VOCs in the headspace of 
the diabetes models. Figure 5.2 shows GC profiles of normal and disease 
model of adipocytes and skeletal muscle cells. VOCs, such as ethyl 5-
methylnonanoate, 17-octadecynoic acid, cis,cis-7,10-hexadecadienal were 
increased, and oxalic acid, 1,6,10-dodecatriene-3-carboxylic acid, 
cyclohexane carboxylic acid were decreased in adipocytes. In skeletal 
muscle cells ethyl 5-methylnonanoate, 17-octadecynoic acid (17ODYA), 12, 
15-octadecadiynoic acid were increased, and dodecanoic acid, 2,5-
octadecadiynoic acid were decreased. Among the analyzed VOCs, 
17ODYA was selected as a biomarker for the diagnosis of insulin resistance 
and was used for the screening of an olfactory receptor. 17ODYA is a 
palmitic acid analogue and blocks leukotriene b4 hydroxylation by LTB4 
hydroxylase resulting in inducing inflammation. The inflammation causes 









Figure 5.1 Construction of in vitro diabetic models. (a) Fluorescence 
images of diabetes model cells with glucose uptakes. (b) Quantitative 




Figure 5.2 Analysis of VOCs in the headspace of diabetes model cells 
using SPME-GC/MS. (a) GC profiles of disease model, (b) normal 






5.3 Screening of human olfactory receptors 
 
Artificial olfactory systems were constructed for the screening of human 
olfactory receptors which can selectively recognize 17ODYA for the 
diagnosis of insulin resistance. Human ORs and accessory proteins were co-
transfected to HEK-293 cells, and CRE-luciferase reporter gene assay was 
performed. We stimulated 86 hORs with 1 mM 17ODYA in triplicate 
(Figure 5.3(a)), and the specificity of the responded receptors was tested 
with cancer biomarkers such as 1,3-dichlorobenzene (MDCB), 2-ethyl-1-
hexanol (2E1H) and hexanal (HEX) (Figure 5.3(b)). As results, OR51A4 
was selected as the specific receptor for the development of the 
bioelectronic nose. Cell surface expression of hOR was analyzed by 
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Figure 5.3 Screening of human olfactory receptors. (a) Responses of 86 
human olfactory receptors to 17ODYA. (b) Selectivity of OR51A4. (c) 




5.4 Construction of nanovesicle-based bioelectronic nose 
 
For the scalable integration of human olfactory receptor onto CNT-FET, 
nanovesicles were produced as described in chapter 4.3. The diameter of 
nanoveislces was approximately 100 nm (Figure 5.4(a)). OR51A4 existed 
in hOR expressing cell-derived nanovesilces (Figure 5.4(b)). The 
functionality of OR51A4 in nanovesicles was analyzed by calcium assay 
with fluorescent dye (Figure 5.4(c). Only nanovesicles containing OR51A4 
have the binding ability with 17ODYA. 
CNT-FET was fabricated via the photolithography method and CNT 
channels were incubated with positively charged PDL. Nanovesicles which 
have negative charges at the surface were immobilized onto PDL-coated 
CNT channels (Figure 5.5(a)). Source-drain current-voltage relationships 
before and after the nanovesicle immobilization were analyzed to identify 
the electrical properties of the bioelectronic sensor. Although the resistance 
was increased, the linearity of the curve was sustained, and stable ohmic 
behavior was observed (Figure 5.5(b)). Figure 5.5(c) shows a liquid ion gate 
profiles of the CNT-FET before and after the nanovesicle immobilization. 
Clear p-type behavior was maintained and these electrical properties 
indicated that the nanovesicle-based bioelectronic sensor can be used for the 
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Figure 5.4 Characterization of olfactory nanovesicles. (a) SEM image of 
nanovesicles. (b) Western blot analysis of OR51A4 in nanovesicles. (c) 
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Figure 5.5 Characterization of nanovesicle-based bioelectronic nose. (a) 
SEM image of nanovesicle-immobilized CNT channels. (b) current-voltage 
curves and (c) gating curves of CNT channels before and after the 





5.5 Detection of 17ODYA using bioelectronic nose 
 
Figure 5.6 (a) shows the real-time current changes of the bioelectronic 
nose with concentrations of 17ODYA from 1 fM to 1 pM. Only olfactory 
nanovesicle nanovesicle-functionalized CNT-FET showed dose-dependent 
responses to 17ODYA. Figure 5.6 (b) shows the normalized sensitivity of 
the bioelectronic nose at different concentrations of 17ODYA before and 
after the immobilization of olfactory nanovesicles, and the detection limit of 
the bioelectronic nose was 10 fM. Figure 5.6(c) and (d) show the selective 
detection of 17ODYA against other cancer markers such as MDCB, 2EH1 
and HEX. These results indicated that the bioelectronic nose functionalized 
with OR51A4 can selectively detect the diabetes biomarker and could be 
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Figure 5.6 Detection of 17ODYA using bioelectronic nose. (a) Real-time 
responses and (b) normalized sensitivity of the bioelectronic sensor with 
various concentrations of 17ODYA. (c) Real-time responses (d) selective 
responses of the bioelectronic sensor to biomarkers before and after the 




   

















Here we constructed the in vitro models of diabetes by inducing insulin 
resistance in mouse adipocytes and skeletal muscle cells. Volatile organic 
compounds from the headspace of in vitro models were identified using the 
SPME-GC/MS methods. 17ODYA was increased in both model cells and 
selected as the potential biomarker of diabetes. Human olfactory receptor 
was screened for the selective recognition of diabetes biomarker, produced 
as nanovesicles for the scalable integration with the CNTs. The 
bioelectronic nose was developed for the diagnosis of diabetes using an 
olfactory nanovesicle and a CNT-FET. The bioelectronic nose could detect 
10fM of 17ODYA in dose-dependent manner and selectively discriminate 
the target odorant from other odorants. This approach can be used as a 
useful tool for developing bioelectronic noses for diagnosis of various 
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Chapter 6. Development of portable and multiplexed 
bioelectronic sensor using human olfactory and taste 




To overcome the limitations of conventional analytical methods, highly 
sensitive and selective bioelectronic sensors that mimics the human 
olfactory/taste system have been developed.49,130,131 The sensors use 
olfactory or taste receptors as primary recognition molecules and 
nanomaterials such as carbon nanotube, 24,25,85,86,89,90,91,92,93,94,104,118, 
conducting polymer88,105 and graphene87,95 as secondary transducers for 
signal amplification from the primary recognition molecules. The sensors 
have both the advantage of the high selectivity of a natural system and the 
high sensitivity of a nanomaterial-based electronic sensor. These sensors 
can be applied to the analysis of food quality,91,92,93,94,105 disease diagnosis89, 
and environmental assessment.90  
Although the sensors distinguish their target molecules with high 
resolution, they cannot recognize complex mixtures like humans perceive. 
The human olfactory and taste systems are activated by the combinatorial 
pattern recognition of various receptors.81,132,133 For an accurate 
representation of the human olfactory/taste system and simultaneous 
analysis of various odors and tastes, multiplexed sensing systems are 
required with different kinds of receptors. In our previous work, the size of 
the sensor was small enough, but the size of the measurement equipment 
was not small enough for on-site analysis. Thus, in addition to multiplexed 
sensing, miniaturization of the monitoring system is necessary for practical 
on-site application of the bioelectronic sensor. 
Herein, we developed a portable and multiplexed bioelectronic sensor 
that combines human olfactory and taste receptors with a multi-channel 
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CNT-FET, which can be used to obtain comprehensive information 
regarding food freshness from various viewpoints. For the multiplexed 
analysis of taste- and odor-causing compounds produced by food, four 
different kinds of receptors were produced in E. coli134 and their structures 
and functional properties were confirmed. The recombinant receptors were 
immobilized onto CNT channels with a uniform orientation using a nickel-
histidine reaction. The CNT-FET sensor was designed as a 4 x 4 multi-
channel type, and all channels were divided by microwells fabricated by 3D 
printing technology. For on-site application, a conventional portable 
monitoring system was customized for the multi-channel type bioelectronic 
sensor, which was operated by a laptop computer. The device successfully 
distinguished the four different molecules, and the pattern recognition of 
complex mixtures was available by the binding of target molecules to their 
specific receptors without any interference from other non-target molecules 
in the mixture. This allowed a successful analysis of various aspects of food 
quality. 
 
6.2 Expression, purification, and refolding of human 
sensory receptors 
 
For the detection of taste and odor molecules, four different kinds of 
olfactory and taste sensory receptors were selected; OR2J2 and OR2W1 for 
octanol, OR2W1 for hexanal,135 TAAR5 for trimethylamine136 and 
TAS2R38 for goitrin.137 These taste and odor molecules are indicators of 
food contamination; octanol for bacterial contamination in beef,138 hexanal 
for lipid oxidation in dairy products,139,140 trimethylamine for seafood 
decomposition,141 and goitrin for antithyroid toxin in vegetables.137 The 
receptor genes were amplified from human genomic DNA and cloned into 
pET-DEST42, a bacterial expression vector. A 6xHis-tag was fused to the 
C-terminus of the receptor proteins for purification and oriented 
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immobilization on the Ni-coated CNTs. The receptor proteins were 
expressed as inclusion bodies in E. coli BL21 (DE3) and solubilized with 
SDS and DTT. They were purified with a His-tag gravity column using pH 
gradient method and reconstituted using a detergent micelle method to 
maintain the original structure of the receptor proteins.  
Figure 6.1(a) shows the SDS-PAGE images of the produced and 
purified proteins. All receptor proteins were successfully expressed withat 
the expected size and purified at high purity. Western blotting was carried 
out using an antibody against the His-tag to confirm its fusion to the 
receptor proteins (Figure 6.1(b)). Their secondary structures were analyzed 
by circular dichroism spectroscopy. Human olfactory and taste receptors are 
mainly composed of alpha helices and possess strong negative bands at 208 
and 220 nm of wavelength.135,142,143 Figure 6.1(c) shows that all 
reconstituted proteins had minimal values at both the predicted wavelengths, 
indicating that they were well-constructed through the reconstitution 
process. The functionality of the proteins was evaluated using a tryptophan 
fluorescence quenching method (Figure 6.1(d)). The fluorescence of 
proteins is mainly due to the excitation of tryptophan residues, and 
conformational changes in proteins upon ligand binding decreases the 
fluorescence intensity by shielding the tryptophan residues.144 In the present 
study, the selected sensory proteins contain several tryptophan residues; 
five residues in OR2J2, three residues in OR2W1, eight residues in TAAR5, 
and nine residues in TAS2R38. Fig. 1d shows that the receptor proteins 
selectively recognize their ligands in a dose-dependent manner. This 
indicates that the produced proteins have the specificity of the human 
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Figure 6.1 Functional production of human olfactory and taste receptors. (a) 
SDS-PAGE and (b) Western blotting analysis of purified and reconstituted 
receptor proteins; olfactory receptors OR2J2, OR2W1 and TAAR5, and 
taste receptor TAS2R38. (c) Secondary structure analysis of olfactory and 
taste receptor proteins. (d) Evaluation of the receptor selectivity with 
octanol, hexanal, trymetylamine and goitrin. Error bars, SD, triplicate. 
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6.3 Fabrication of multi-channel bioelectronic sensor 
 
Figure 6.2(a) is a schematic diagram representing the fabrication 
process of a multi-channel sensor (MCS) and channel splitter. The MCS 
was fabricated using a previously reported method (detailed in Materials 
and Methods).24,89,104 Briefly, the electrodes and channels were patterned 
onto an SiO2 wafer via the photolithography method, and the patterned 
wafer was incubated in SWCNT solution. A passivation layer was created 
on the electrodes to prevent the leakage of current under aquatic conditions. 
The fabricated MCS had four quadrants, each composed of four 
compartmentalized CNT network channels. The CNT network channels 
were functionalized with an Ni component for immobilization of the four 
types of receptors using a method reported in previous papers.118,145 The 
MCS was incubated in 4-carboxybenzene diazonium tetrafluoroborate 
solution to functionalize the SWCNTs on the channels. Subsequently, the 
carboxylic acid of the 4-carboxybenzene was activated in activation buffer 
and was immersed in N,N-bis(carboxymethyl)-L-lysine hydrate (NTA-
NH2) solution. Finally, the MCS was washed with deionized water and 
placed in a solution of NiCl2 for the functionalization of Ni
2+ on SWCNTs. 
A channel splitter was fabricated using a 3D printer, and designed with 
the different wall heights to prevent various solutions from mixing with 
each other. The wall inside the quadrant (X-shaped walls) plays a role in 
splitting the inner part of the MCS, preventing one receptor solution from 
mixing with another during the receptor immobilization process. The outer 
wall helps to set a consistent solution volume on the channel parts and 
block the solution from contacting the pads. The channel splitter was coated 
with a thin layer of polydimethylsiloxane (PDMS) to prevent the leakage of 
solutions, and was fixed on the channel part of the MCS. The assembled 
MCS was baked at 120 °C for 30 min to cure the PDMS. 
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Figure 6.2(b) and (c) are optical images of the MCS with the channel 
splitter. Each quadrant is composed of four CNT network channels, each of 
which has 160 individual parallel CNT network lines (indicated by the 
yellow arrows in Figure 6.2(d). The CNT networks were laid out in an 
interdigitated shape to minimize the size of the sensor. Figure 6.2(d) shows 
an atomic force microscopy (AFM) image of parallel CNT network lines. 
The length and width of one CNT network line are 100 µm and 3 µm, 
respectively. In a multiplexed sensing system, the deviation of device 
characteristics plays an important role in data analysis. Figure 6.3 shows the 
effect of the CNT network line number on the deviations of device 
characteristics. Each value was averaged from sixteen devices for data 
analysis. The graphs show that deviations decreased as the number of CNT 
network line increased. For 160 CNT network lines, the deviations of 
device characteristics decreased to 30% compared with 40 CNT network 
lines. This result indicates that the large number of CNT network lines 
decrease the variation among numerous sensor devices and enhance the 
reliability of sensor performance. 
We investigated the characteristics of pristine MCSs and various 
receptors-immobilized MCSs using AFM. Figure 6.2(e) shows AFM 
topography images prior to and following receptor immobilization on CNT 
network channels. We measured AFM images in tapping mode with a scan 
rate of 0.4 Hz for pristine CNT channels. Following imaging of pristine 
CNT networks, receptors were immobilized on the channels and the AFM 
image was scanned at the same location of the channel, with a scan rate of 
0.1 Hz to avoid unintended noise signals from sticky biomolecules. Figure 
6.2(e) shows cross-section profiles on the horizontal lines of the upper AFM 
images. The heights of the CNT networks increased following 
immobilization of receptors, especially at some prominent peak points. 
Following the immobilization of OR2J2, OR2W1, TAAR5, and TAS2R38 
on the CNT networks, the heights were increased by approximately 1.94, 
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1.82, 2.82, and 1.74 nm, respectively, compared with the pristine ones. The 
increased heights are considered to be evidence of successful receptor 
immobilization on the CNT networks. 
Figure 6.2(f) shows the electrical characteristics of MCSs prior to and 
following the immobilization of four types of sensory receptor on the CNT 
network channels. We measured characteristics I-V and liquid gate profiles 
of MCSs using a semiconductor analyzer. The blue and red lines are the 
electrical characteristics of the pristine and receptor-immobilized MCSs, 
respectively. The graphs show the formal p-type semiconductor 
characteristics regardless of receptor immobilization, indicating that 
receptor immobilization on the CNT networks does not significantly affect 














Figure 6.2 Fabrication and characterization of a multi-channel CNT-FET 
sensor. (a) Schematic diagram of an olfactory and taste receptor-
functionalized multi-channel-type CNT-FET platform. (b) Optical image of 
a multi-channel-type CNT-FET and (c) CNT channels. (d) SEM image of 
CNT channels. (e) AFM images and height profiles of CNT channels prior 
to and following functionalization with receptors. (f) Current-voltage curves 
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Figure 6.3 Effect of the channel number on the standard deviations of 





6.4 Detection of odor and taste molecules using 
bioelectronic sensor 
 
We also developed a customized portable measurement system for the 
detection of various molecules using the MCSs (Figure 6.4(a)). The 
portable system is composed of 20 probes, a 16-to-1 multiplexer and a 
microcontroller unit to switch from one channel to another. A 
HyperTerminal was used as the platform for instrument control. We applied 
bias voltages of 0.1 V to the reference pads and measured the current 
signals with a resolution of 10-10 A. 16 probes were utilized for the 
measurement of conductance changes, and the other 4 probes were used as 
the reference pads. The channels were switched sequentially from 1 to 16, 
and repeated 3 times. This platform was designed to be connected to a 
laptop computer via a USB cable for its portable application. When odor 
and taste molecules were injected into the multi-channel-type CNT, the 
receptor-functionalized channel showed conductance changes with high 
selectivity (Figure 6.4(b)). There were no significant changes in 
conductance at the pristine CNT channels (Figure 6.5). The change in 
conductance was normalized to the maximum response, and Figure 6.4(c) 
shows the normalized sensitivity and distinguishing ability of the sensor at 
different concentrations of specific target molecules. The dose-dependent 
signals were analyzed with the Langmuir isotherm and the calculated Kd 
values were 7.53 x 1012 M-1 for OR2J2 and octanol, 3.05 x 1010 M-1 for 
OR2W1 and octanol, 2.31 x 1011 M-1 for OR2W1 and hexanol, 1.97 x 1011 
M-1 for TAAR5 and trimethylamine, and 1.782 x 1012 M-1 for TAS2R38 and 
goitrin. The human olfactory system is known to recognize a smell by the 
sum of receptor binding, and antagonistic interactions of olfactory receptors 
have been reported,146 thus, interference effects between the receptors and 
odor molecules were examined. When we compared the electrical signals of 
each target molecule and the target molecules in mixtures, non-target 
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molecules in the mixture did not affect the electric signal and intrinsic 
signals of the target molecules were obtained even in the mixtures. (Figure 
6.4(d)) These results show that the target molecule can be detected 
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Figure 6.4 Detection of target molecules using a customized monitoring 
platform. (a) A photograph of the portable and multiplexed bioelectronic 
sensor connected to a laptop computer. (b) Signal pattern recognition of 
each odor and taste molecule by the bioelectronic sensor (the concentrations 
of target molecules were fixed at 1 nM). (c) Normalized sensitivity of the 
sensor based on each sensory receptor. (d) Signal pattern recognition of 







Figure 6.5 Responses of pristine CNT-FET to octanol, hexanal, 




6.5 Assessment of food freshness using biolelectronic 
sensor 
 
Food is the major source of human nutrition in order to maintain a 
healthy life. Nobody wants to eat stale food, and consumption of 
contaminated food can lead to serious diseases, therefore, it is important to 
control food quality in various food industries.147 There are many 
conventional methods for the assessment of food quality; 1) physical 
(viscosity, chromaticity, turbidity, solubility), 2) physicochemical (moisture, 
acid value, sugar content, nutritional content analysis), 3) microbiological 
challenge (bacterial counts) method, and 4) human sensory test (appearance, 
flavor, taste, texture).148 However, these methods are not suitable for rapid 
analysis due to their invasive and complex pretreatment steps, long 
analytical times and requirement for an expert. To overcome the limitations 
of the conventional methods, we applied our bioelectronic sensor to the 
assessment of food quality. Since our target molecules, such as octanol, 
hexanal, trimethylamine, and goitrin, are known to be indicators of food 
contamination, it was expected that we would detect these molecules in 
various kinds of foods, therefore we measured the response of the 
bioelectronic sensor to treatment with several food samples. Various food 
samples were stored in a refrigerator and analyzed by the bioelectronic 
sensor every day (Figure 6.6). Among the prepared food samples, banana, 
strawberry, potato, and chicken did not induce any significant current 
changes in the sensor. However, in the case of beef and pork samples, a 
signal change was observed in the OR2J2-functionalized channel after 3 
days, and in the OR2W1-functionalized channel after six or seven days. In 
the case of cheese and milk, the octanol concentration increased after two 
days. Trimethylamine began to be detected from both oyster and shrimp 
after day one and day three, respectively. Goitrin, which is an antithyroid 
toxin, was observed in broccoli and cabbage. Interestingly, the signal 
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intensity induced by broccoli and cabbage did not increase with storage 
time and was steadily maintained from day zero to day seven. These results 
indicate that our sensor can be effectively used for simultaneous analysis of 




Figure 6.6 Signal pattern analysis of various food samples. Error bars, SD, 









In the present study, by the integration of human olfactory/taste 
receptors to the multi-channel CNT-FET platform with channel splitter, we 
developed a portable and multiplexed bioelectronic sensor for the 
simultaneous detection of the target molecule in the mixtures. The sensing 
device selectively distinguished mixtures of these molecules as well as 
individual odor and taste molecules with high sensitivity, and became 
portable by combining the miniaturized current measurement system with 
the carbon nanotube so that electrical signals can be rapidly analyzed in the 
field in real-time. From our results, it is expected that this multiplexed 
bioelectronic sensor can be used as a useful tool for the quality assessment 
of various foods and for diverse on-site detection of various molecules by 










Development of peptide-based 
bioelectronic sensor using extracellular 





Chapter 7. Development of peptide-based bioelectronic 
sensor using extracellular loops of aquaporin for the 




Neuromyelitis optica (NMO, also known as Devic’s disease) is a severe 
and uncommon disease of the central nerve system (CNS) that principally 
attacks the optic nerves and spinal cords.149,150 The symptoms of the disease, 
including blindness and paralysis, are very serious. NMO is commonly 
confused with multiple sclerosis (MS) because the symptoms are similar. 
Since the treatments for the two diseases are different, an accurate diagnosis 
in the early phase is important. In 2004, NMO-IgG was found to be a highly 
specific biomarker in human blood and enabled the differentiation of NMO 
and MS patients.151,152 This disease’s specific antibody targets aquaporin-4 
(AQP4), a transmembrane protein expressed in the CNS, that regulates 
water transport in astrocytes and ependymal cells. Various laboratory tests 
using AQP4 were developed for the detection of AQP4 antibody with 
tissue-, cell- and protein-based assays.153,154,155,156,157,158,159,160 However, these 
methods have the limitations such as low sensitivity and long analytical 
time for diagnosis. 
In a recent study, three extracellular loops (A, C and E) of AQP4 were 
found to contain disease-specific epitopes, which could be used in an assay 
for the diagnosis of NMO.161,162 In order to overcome the drawbacks of 
existing methods, we propose a peptide-based CNT biosensor for the rapid 
detection of AQP4 antibody in human serum. A CNT-based FET has been 
used for the rapid detection of biological molecules with high sensitivity. 
CNTs have a large surface to volume ratio due to their unique one-
dimensional nanoscale structures. Thus, the electrical properties of CNTs 
could be easily changed by adsorptions of biomolecules onto their surfaces. 
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We synthesized AQP4 extracellular loop peptides and directly immobilized 
them onto CNT channels. Using this biosensor, we could detect AQP4 
antibody, a biomarker of NMO disease, with a detection limit of 1 ng/l. 
Furthermore, the sensor was able to detect the antibody without any 
pretreatment of the human serum. 
 
7.2 Construction of peptide-based bioelectronic sensor 
 
Three kinds of AQP4 extracellular loop peptides were synthesized, and 
three molecules of phenylalanine (Phe) were added to the C-terminus in 
order to immobilize the synthesized peptides onto CNTs via pi-pi 
interactions between CNTs and the aromatic rings of Phe.12,13 In order to 
have a maximal capacity for antibody sensing, sufficiently high 
concentrations of the peptides were immobilized on the CNT channels as a 
monolayer via self-assembly and unbounds were washed away with 
distilled water. The fabricated CNT biosensor could detect AQP4 antibody, 
which had a pI value of 9-10 and was positively-charged in PBS of pH 7.4, 
with a decreased conductance. Figure 7.1 shows the sensing mechanism of 
the AQP4 loop peptide-based biosensor. 
To confirm the immobilization of the peptides, an AFM image analysis 
was performed. Figure 7.2(a) shows the AFM images of the CNT channels 
before and after the immobilization of three kinds of AQP4 extracellular 
loop peptides. When we compared the height profiles of specific CNT 
regions, the height was increased by 0.71 ± 3.13 nm with AQP4 loop A, 
0.56 ± 2.9 nm with AQP4 loop C and 1.4 ± 2.9 nm with AQP4 loop E 
(Figure 7.3(b)). These results show a successful immobilization of the 





Figure 7.1 Schematic diagram showing the sensing mechanism of an AQP4 
loop peptide-based CNT-FET biosensor. Positively-charged AQP4 antibody 
binds with the AQP4 extracellular loop peptides on CNTs, which gives a 











Figure 7.2 Immobilization of peptides onto the CNT channels (a) AFM 
images of a CNT channel before and after the immobilization of AQP4 
extracellular loop peptides. (b) Comparison of measured height profiles of 












7.3 Electrical characteristics of peptide-based 
bioelectronic sensor 
 
To evaluate the electrical property of the biosensor, the source-drain 
current-voltage (ISD-VSD) of CNT channels was measured (Figure 7.3(a)). 
Although the resistance of the FET sensor was increased from 6.55 × 105 Ω 
to 1.54 × 106 Ω with AQP4 loop A, 6.57 × 105 Ω to 1.23 × 106 Ω with 
AQP4 loop C and 6.59 × 105 Ω to 1.11 × 106 Ω with AQP4 loop E, the 
linearity of the curve was maintained before and after the immobilization of 
the peptides. We constructed a liquid-ion gated FET system with PBS 
(pH7.4). The source-drain current of the CNT channel was measured while 
increasing the gate voltage (Figure 7.3(b)). The current between the source 
and the drain (ISD) decreased with an increasing gate voltage (VG), 
indicating p-type FET behavior. These electrical characteristics indicate that 








Figure 7.3 Electrical characteristics of peptide-based bioelectronic sensor. 
(a) Current-voltage curves and (b) Gate profiles of the CNT-FET before 






7.4 Detection of AQP4 antibody using bioelectronic 
sensor 
 
The sensing ability of this sensor was evaluated using antibodies in PBS 
solution. A PBS droplet of 20 µl was added to the peptide-immobilized 
CNT channel, and the sample solution containing AQP4 antibody (ab46182, 
Abcam, UK) was injected. Figure 7.4(a) shows the real-time conductance of 
the sensor with concentrations of AQP4 antibody ranging from 1 ng/l to 1 
µg/l. Each AQP4 extracellular loop peptide-based sensor showed a dose-
dependent response. The sensor was able to detect AQP4 antibody at a 
concentration as low as 1 ng/l with AQP4 loop E. In our previous research 
for the detection of AQP4 antibody, nanovesicle-based CNT biosensor 
showed the detection limit of 10 ng/l antibody.108 The LOD was improved 
by ten-fold due to the shortened distance between CNTs and antibody, since 
the small size peptides were used.  Figure 7.4(b) shows the normalized 
sensitivity of each peptide to different concentrations of AQP4 antibody. 
AQP4 loop E showed the highest sensitivity to AQP4 antibody among the 
three peptides. This result was attributed to the different affinity of each 










Figure 7.4 Detection of AQP4 antibody using peptide-based bioelectronic 
sensor. (a) Real-time responses of AQP4 loop peptide-based CNT-FETs to 
AQP4 antibody at concentrations ranging from 1 ng/l to 1 µg/l. (b) 
Normalized sensitivity of biosensors based on pristine CNTs (black line), 
CNTs functionalized with AQP4 loop A (red line), C (green line) and E 




7.5 Detection of AQP4 antibody in human serum using 
bioelectronic sensor 
 
It was reported that the antibody level of NMO patients is 13.984 ± 
5.981 g/l.163 To evaluate the usability of the sensor for the diagnosis of 
NMO, 1g/l of AQP4 antibody in human serum (H4522, SIGMA, US) was 
tested. Serum samples containing AQP4 antibody were prepared to 1:105 
dilution in PBS to avoid a non-specific response (Lim et al., 2014). As 
shown in Fig. 5a, the sensor did not respond to the human serum without 
AQP4 antibody, but the conductance decreased when antibodies were 
present in the serum samples. The RSD values were 8.33% with AQP4 loop 
A, 23.08% with AQP4 loop C and 2.17% with AQP4 loop E (n = 3) (Fig. 
5b). These results indicate that the sensor can be effectively used for the 
rapid and easy diagnosis of NMO. This biosensor is for a single-use. It was 
difficult to recover the current signal after use, since the binding of antibody 
and peptide was not completely removed with washing process. However, 
mass production of CNT-based sensor is available with the lithography 
method and it requires only a small volume of peptide for the 
functionalization. It also has advantages in simple and fast detection of 









Figure 7.5 Detection of AQP4 antibody in human serum using peptide-
based bioelectronic sensor. (a) Real-time response to 1 g/l of AQP4 
antibody in 1/105-diluted human serum. (b) Quantitative comparison of 
conductance change among AQP4 extracellular loop A (red line), C (green 






We developed a rapid sensor for the diagnosis of NMO using peptide-
based CNT-FET. AQP4 extracellular loop peptides, which bind with the 
serum biomarker of NMO, were synthesized and three molecules of Phe 
were added to the C-terminal for immobilization on CNTs. The synthesized 
peptides were directly immobilized onto CNT channels in the FET sensor. 
The constructed biosensor showed p-type FET characteristics and could 
detect a positively charged antibody. The sensor can detect 1 ng/l of AQP4 
antibody with the AQP4 loop E peptide. Moreover, human serum antibody 
was detected without any pretreatment. Due to its high sensitivity and 
rapidity, this biosensor can be effectively used as a simple and easy 












Overall discussion  








Chapter 8. Overall discussion and further suggestions 
 
Bioelectronic sensors that combine biomolecules and electronics have 
been developed for sensitive and selective analytical tools. Biomolecules, 
such as DNA, protein, and cells, were used as primary recognition elements. 
Carbon nanomaterials, such as carbon nanotubes, conducting polymers and 
graphene, were utilized for rapid signal amplifications. Various receptor-
ligand bindings and their action potentials were compatible to convert into 
electrical signals. The bioelectronic sensors have advantages in cost 
efficiency, small size, fast response, high sensitivity and selectivity. It is 
expected that integrating various kinds of receptors with carbon 
nanomaterials could be applied to diverse areas in the human life. 
In the thesis, CNT-based bioelectronic sensors using receptor proteins 
and peptides were developed and applied to environmental monitoring, 
disease diagnosis and food quality assessment. 
In chapter 4, a bioelectronic sensor using human olfactory nanovesicle 
for detection of odor compounds in water pollution was presented. Artificial 
olfactory systems were constructed and hORs were screened as specific 
receptors for the detection of water contamination indicators. Olfactory 
nanovesicles were produced from the mammalian cells expressing the hORs. 
CNT-FETs were functionalized with the olfactory nanovesicles. The 
bioelectronic nose sensitively and selectively detected target molucules and 
the detection limit was 10 mg/l, a sufficiently low level for the assessment 
of water quality. The water contamination indicators were detected in 
various water samples without pre-treatment. These results offer the simple 
and rapid method for monitoring of water quality in real environments. 
In chapter 5, a bioelectronic sensor using human olfactory nanovesicle 
for detection of VOCs from in vitro diabetic models was presented. In vitro 
models of diabetes were constructed by inducing insulin resistance in 3T3-
L1 adipocytes and L6 skeletal muscle cells with a treatment of palmitic acid. 
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VOCs in the headspace of both cells were collected and analyzed using 
SPME-GC/MS. 17ODYA was selected as the potential biomarker for early 
diagnosis of diabetes. Human OR was screened for the selective recognition 
of 17ODYA and produced from the artificial olfactory cells as nanovesicles. 
The nanovesicle-based bioelectronic nose detected 10 fM of 17ODYA in 
dose-dependent manner with high selectivity. This approach can be used for 
efficient diagnosis of diseases that biomarkers are not known. 
In chapter 6, a portable and multiplexed bioelectronic sensor using 
human olfactory and taste receptor proteins for assessment of food quality 
was presented. Olfactory and taste receptors were produced in E. coli, and 
immobilized onto a multi-channel CNT-FET. A miniaturized current 
measurement platform was combined with the multi-channel bioelectronic 
sensor and electrical signals against four different food contamination 
indicators were simultaneous detected. Various pattern recognitions of 
complex mixtures were successfully analyzed with the developed device. 
The bioelectronic device was suitable for monitoring of food freshness and 
is expected to be used as an on-site sensing platform. 
In chapter 7, a peptide-based bioelectronic sensor using extracellular 
loops of aquaporin for diagnosis of NMO was presented. AQP4 
extracellular loop peptides were synthesized with the addition of triple Phe 
in C-terminal and immobilized onto CNT channels. The peptide-based 
bioelectronic sensor detected 1 ng/l of NMO-IgG with AQP4 loop E 
peptide. Antibodies in human serums were detected without pretreatment. 
The bioelectronic sensor can be used for rapid and simple detection of 
disease biomarkers. 
In this research, nanovesicles derived from receptor expressing cells, 
proteins produced in E. coli and peptides derived from receptors were 
utilized as primary recognition elements of the bioelectronic sensors. 
Nanoveislces were immobilized onto PDL-coated CNT-FET surface using 
charge-charge interactions, proteins were immobilized onto Ni-modified 
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CNT-FET using Ni-NTA interactions, and peptides were directly 
immobilized CNT channels using pi-pi interactions CNTs and the aromatic 
rings of Phe. In the nanovesicle-based bioelectronic sensors that mimic the 
human olfactory mechanism, odor and olfactory receptor binding triggered 
calcium influx in nanovesicles and influenced the current changes of the 
transistor. In the protein-based bioelectronic sensors, structural changes of 
charged amino acids in the receptor proteins influenced the current changes. 
In the peptide-based bioelectrocnic sensors, positively charged target 
molecules influence the field effect on the transistor. 
For environmental monitoring, the water contamination indicators, 
GSM and MIB, were specifically recognized by hOR51S1 and hOR3A4. 
For food quality assessment, octanal (beef contamination indicator) was 
detected with OR2J2 and OR2W1, hexanal (lipid oxidation indicator) was 
detected with OR2W1, TMA (seafood decomposition indicator) was 
detected with TAAR5, and goitrin were detected with TAS2R38. For the 
disease diagnosis, 17ODYA, VOC in the diabetes in vitro model, was 
detected with hOR51A4, and NMO serum biomarker was detected with 
AQP4 extracellular loop-derived peptide. Using athe combination of novel 
receptors and nanomaterial-based transistor, bioelectronic sensors are 
expected to be applied in various new area. 
For the practical application of bioelectronic sensors, the miniaturized 
current measurement was customized with the receptor-functionalized 
CNT-FET sensor. The combined bioelectronic device was operated with 
laptop computer and the portability of the bioelectronic sensor was 
promoted. Multiplexed bioelectronic sensor enabled the simultaneous 
detection of different target molecules and pattern recognitions of target 
molecules were available. These techniques can improve the accuracy of 
the detected sensor signals. 
Reusability of the bioelectronic sensors is also important for their 
practical applications. Protein- and peptide-based bioelectronic sensors are 
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relatively stable than nanovesicle-based bioelectronics sensors and can be 
used again after washing steps. However, nanovesicle-based bioelectronic 
sensors, which utilized calcium ion influx as signal measurement principles, 
cannot be reused. When calcium ions inside nanovsicles are saturated, the 
nanovesicle-based sensors cannot discharge calcium ions. Recently, an ion-
channel-coupled receptor-based platform was developed for the 
measurement of GPCR activities.164 This platform uses GPCR fused with a 
Kir 6.2 channel and potassium ion influx as current change principles. With 
the integration of outward-rectifying potassium channels such as blue light-
induced and voltage-gated potassium channels.165,167 The nanovesicle-based 
bioelectronic sensors are expected to be reused with the controlled influx 
and outflux of potassium ions. 
Moreover, we compared bioelectronic sensor using receptor proteins 
with traditional methods. When freshness of oyster samples was analyzed 
with the bioelectronic sensor, human sensory evaluation and GC/MS, the 
bioelectronic sensor has positive correlation with other analytical methods. 
The signal observed with the bioelectronic sensor was two days faster than 
other methods. These results offer the rapid and simple tool for early 
detection food contamination. It is also expected that the sensitive 
bioelectronic sensor using disease-related receptor proteins can be 
developed for novel diagnostic tools which have difficulty in early-phase 
detection. Bioelectronic sensors that have the selectivity of the nature 
system and the sensitivity of nanoelectronics can be used for the study of 
unknown phenomena of the currently existing experimental methods. The 
combinatorial developments of bioelectronic sensors and biogenerators 
could be applied to not only biological signal detections but also 
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초    록 
 
생체 질  인지요소  사용 고 자장 를 신 변  사
용 는 이 자 는 많  분야에  리 개 어 다. 생
 요소에  감   상 질 검지를   능
 증진시 다. 나노소자   장 는 신속히 생체신
를 증폭 여 직 인 태  다. 군다나 많  생  
동 에 해 작동 여 그 커니즘이 이 자 에 용
  있다. 근 들어 탄소나노튜 , 그래 , 나노 티클, 나노
이버, 나노 름 등 다양  나노소자들이 이 자  작에 
사용 었다. 이러  나노소자들  특이 인 결합  해  DNA, 
단 질, 펩타이드, 포 등  생체 질과 함께 능 었다. 이
게 작  이 자 들  낮  가격, 작  크 , 른 신 , 
높  민감도  택도에  장 이 있다. 
본 연구는 탄소나노튜   이 자 를 용체 단
질과 펩타이드를 이용 여 작 고 다양  분야에 용 는 것
에 목 이 있다. 용체는 포막 외부  자극  인해 신 달
체계를  시킨다. 용체는 인간  몸 안에  감각 신 달, 
포 상 작용, 신경 달, 르몬 신 달 등 요  역  담
당 다. 본 연구에 는 용체 단 질  포 래  나노베시클, 
 단 질, 합  펩타이드 태  생산 다. 용체에  
생체신 는 탄소나노튜   트랜지스 에 해 었 며 
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이는 경 모니 링, 질병진단, 식품품질평가  분야에 용 었
다. 
후각 용체  능  인  해, 이종 포에  리포
자 시스  이용  인공 후각 포를 작 다. 이 마
커  검지를  특이 인 용체가 별 었고, 별  용체
는 포막에  인 다. 탄소나노튜  신 달  
해 인공 포 래  나노베시클  작 다. 탄소나노튜  
 계 효과 트랜지스 는 통 인 포토리소그래  법
 작 었다. 작   탄소나노튜  채  나노베시클  
능 었고, 나노베시클 고  후에도   특 이 
지 었다. 나노베시클  이 자 는 상 질  높
 민감도  택도  검지 다. 용체 단 질  이용  이
자 는 질 모니 링과 당뇨 진단   간단 고 신속
 분  법  용 었다. 
이 자  실용 를 해 는 다   랫폼  
개 과 소   장 가 요 다.  종류  용체 단 질
 장균에  고,  후 계면 를 이용 여 마이
 안에 구조를 재 다. 생산  단 질들  다채  탄소나
노튜  계 효과 트랜지스 에 고 었 며,  채 들  
상 질들  동시 이 가능 도  자인 었다. 류  
는 작  다채  에 맞춤 작 어 노트북에  공 는 
원에 해 작동 었다. 작  에  다양  질에  복
잡  인식이 상 질  간  상 없이  가능 다. 
간단 고  가능  이 자  효 인 식품품질평가
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가 가능 며 신속  장  랫폼  용  것이 
었다.  
용체 단 질 래  펩타이드를 리간드 결합 부분  시퀀스
를  합 다. 펩타이드는 포막과 같  주변 경  
요  지 않  에 쉽게 합 이 가능 며 보 이 용이 다. 
군다나 합  펩타이드는 말단에 페닐알라닌  추가 는 간단
법  탄소나노튜  이 상 작용  이용 여 직 인 고
가 가능 다. 용체 래  펩타이드  이 자 
는 시신경 척 염  청 이 마커를 높  특이도  검지 다. 
군다나, 존  법 보다 민감도가 욱 뛰어나 그 상  
 검출이 가능  것  다. 
본 연구에 는 탄소나노튜  나노베시클, 단 질, 펩타이드 
같  다양   용체를 이용 여 간단 고 르게 이 마
커를 는 법  개 다. 개  는 경 모니 링, 
질진단, 식품 염평가에 용 었 며  가능  다  
가 사용 었다. 
 
주요어: 이 자 , 용체, 탄소나노튜 , 경 모니 링, 
질병 진단, 식품 품질 평가 
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